NPPB and hypertensive disorder: As inflammatory mediators are elevated in hypertensive patients with LVH, this might explain in part the significant elevation of NT-proBNP levels compared with patients without hypertrophy and therefore, this also implies new therapeutic options to improve hypertension treatment in the future.